Adamis Pharmaceuticals Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.1M
Doctors Paid
3
Transactions
511
2022 Total
$2.1M
Payment Breakdown by Category
Research$2.1M (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.1M | 511 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients | $2.0M | 3 | 510 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Infectious Disease | $6,950 | 3 | $2,317 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Cameron Wolfe, Md, MD | Infectious Disease | Durham, NC | $2,700 | $0 |
| Dr. Michael Ison, M.d., M.s, M.D., M.S | Infectious Disease | Falls Church, VA | $2,250 | $0 |
| Shmuel Shoham, Md, MD | Infectious Disease | Baltimore, MD | $2,000 | $0 |
About Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation has made $2.1M in payments to 3 healthcare providers, recorded across 511 transactions in the CMS Open Payments database. In 2022, the company paid $2.1M. The top product by payment volume is ZIMHI ($55,000).
Payments were distributed across 1 medical specialties. The top specialty by payment amount is Infectious Disease ($6,950 to 3 doctors).
Payment categories include: Research ($2.1M).